10 expert webinars coming up this week
Explore topics from HRIM-MS for enhancing structural characterization to microbial monitoring, in situ hybridization and advances in fragrance profiling
Explore topics from HRIM-MS for enhancing structural characterization to microbial monitoring, in situ hybridization and advances in fragrance profiling
Discover how to increase precision and reduce throughput time of your routine electrolyte analyses
Learn how COVID-19 serology testing may inform long-term vaccination strategy and influence short-term prioritization and delivery
Watch this on-demand webinar to learn about the commercial responsibilities of new in vitro diagnostic regulations
Infectious disease expert shares how robust LC columns are facilitating the analysis of complex pathogen samples
Dr. Frank Peacock discusses the impact of delayed care in the ED setting, the power of high-sensitivity troponin assays, and the value of point of care
Labs processing 2,000 to 5,000 tests a day can finally enjoy the benefits of Total Laboratory Automation (TLA) with a compact workflow-automation solution that fits needs
Explore topics from LC-MS for oligos, peptides, glycans, and large molecule characterization to 3D cell culture for anticancer therapies
KSQ Therapeutics uses technology created at MIT to study the role of every human gene in disease biology
New, reversible CRISPR method can control gene expression while leaving underlying DNA sequence unchanged
Vaccine, trialed in 450 children, shows favorable safety profile and was well-tolerated
COVID-19 infections fell by 65% percent after a first dose of the Oxford-AstraZeneca or Pfizer-BioNTech vaccines in this large community surveillance study
A new Prenetics Innovation Technology Centre will be established for advanced molecular diagnostics
First rapid antigen test with performance data on children
Sensor could be used in discovering new treatments for mental illness, in neuroscience research and to detect drugs of abuse
Anti-cancer drug delivery to target tumor sites now becomes more effective with novel multi-stimuli-responsive drug delivery systems
An insider’s view on leveraging the latest single-cell technologies, including cell sorting and single-cell sequencing, to understand what drives response or resistance in checkpoint therapies
The company will receive up to $5 million in grant funds from DARPA as part of the agency’s Nucleic Acids On-Demand World-Wide Program to plan for and prevent the next viral pandemic